GT Biopharma (GTBP) SEC Filings & 10K Form $1.74 -0.18 (-9.11%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Recent GT Biopharma SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView11/27/20243:05 PMGT Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/21/20248:25 AMGT Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/21/20248:13 PMGT Biopharma (Issuer)URBAN ALAN LOUIS (Reporting)Form 4Statement of changes in beneficial ownership of securities 10/17/202410:15 AMCYTOVANCE BIOLOGICS INC (Filed by)GT Biopharma (Subject)Form SCHEDULE 13G/A07/02/20243:50 PMGT Biopharma (Filer)Form 424B306/30/202411:15 PMGT Biopharma (Filer)Form EFFECT06/27/202410:17 AMGT Biopharma (Filer)Form S-1/A06/27/20248:34 AMGT Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/26/20243:17 PMGT Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/18/20248:36 PMGT Biopharma (Filer)Form S-1Registration statement under Securities Act of 1933 06/17/20243:26 PMGT Biopharma (Filer)Form DEFA14A06/07/20244:25 PMGT Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/23/20247:31 PMBRISTOL INVESTMENT FUND LTD (Filed by)GT Biopharma (Subject)Form SC 13G/A05/23/20245:04 AMGT Biopharma (Filer)Form 424B505/23/20245:02 AMGT Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/15/20244:00 PMGT Biopharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 04/30/20242:26 PMGT Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/26/20244:00 PMGT Biopharma (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 02/14/20241:46 PMARMISTICE CAPITAL, LLC (Filed by)GT Biopharma (Subject)Form SC 13G/A02/01/202411:15 AMGT Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies INKT 10K Form LSTA 10K Form CLDI 10K Form ATHA 10K Form MTEX 10K Form GOVX 10K Form IBIO 10K Form PULM 10K Form NNVC 10K Form INAB 10K Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:GTBP) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GT Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GT Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GTBP Stock Alerts